Page 45 - BH-2-1
P. 45

Brain & Heart                                                                 Practical tips for AD and PD



            deficits is a common denominator in both neurologic   Ethics approval and consent to participate
            conditions, the trajectories of functional deterioration of
            these conditions are distinctly demarcated. The utilization   This study was approved by the local Ethics Committee
            of tools like BDRS facilitates a deeper understanding of the   of Mersin University (MEU.2013-304, October 10 2013).
            nuanced behavioral and functional manifestations unique   Written informed consent form was obtained from all
                                                               participants.
            to each disorder. AD typically presents with a progressive
            decline in daily functioning, including ADLs and   Consent for publication
            instrumental ADLs (IADLs), which involve widespread
            cortical involvement. Conversely, PD-D often has a   There  is  no identifying  information of  the  patients that
            relatively preserved functional capacity in the early stages,   appear in writing or within photograph.
            reflecting its etiological link to subcortical pathology,   Availability of data
            but later manifests motor and non-motor symptoms that
            significantly impact on independence. This differentiation   The data used in this paper were obtained from a case-
            in functional decline has profound implications for clinical   sensitive database that requires an institutional or
            decision-making, as it guides tailored interventions and   physician-based subscription. Data used in this work are
            care planning. By recognizing the divergent trajectories   available from the corresponding author on reasonable
            of functional decline, clinicians can refine diagnostic   request.
            accuracy and formulate personalized treatment strategies.
            This approach, augmented by the promises of big data and   References
            patient-centered care, culminates in enhanced outcomes   1.   Perl DP, Olanow CW, Calne D, 1998, Alzheimer’s disease
            and improved quality of life for individuals grappling with   and Parkinson’s disease: Distinct entities or extremes of a
            the  multifaceted challenges  of  dementia. In  embracing   spectrum of neurodegeneration? Ann Neurol, 44: S19–S31.
            this comprehensive approach, health-care providers can      https://doi.org/10.1002/ana.410440705
            navigate the complex landscape of AD and PD-D more   2.   Ballard C, Gauthier S, Corbett A, et al., 2011, Alzheimer’s
            effectively,  providing  not  only  early  diagnosis  but  also   disease. Lancet, 377: 1019–1031.
            optimizing ongoing care and support to enhance the lives
            of those affected by these devastating conditions. In the      https://doi.org/10.1016/S0140-6736(10)61349-9
            future, new prospective studies involving larger patient   3.   Hardy J, Selkoe DJ, 2002, The amyloid hypothesis of
            cohorts should be conducted to further dissect their   Alzheimer’s disease: Progress and problems on the road to
            differences.                                          therapeutics. Science, 297: 353–356.
                                                                  https://doi.org/10.1126/science.1072994
            Acknowledgments
                                                               4.   Gurvit H, Emre M, Tinaz S, et al., 2008, The prevalence of
            None.                                                 dementia in an urban Turkish population. Am J Alzheimers
                                                                  Dis Other Demen, 23: 67–76.
            Funding
                                                                  https://doi.org/10.1177/1533317507310570
            None.                                              5.   Jack CR Jr., Knopman DS, Jagust WJ, et al., 2013, Tracking
            Conflict of interest                                  pathophysiological processes in Alzheimer’s disease: An
                                                                  updated hypothetical model of dynamic biomarkers. Lancet
            The authors declare that there are no conflicts of interest.  Neurol, 12: 207–216.
                                                                  https://doi.org/10.1016/S1474-4422(12)70291-0
            Author contributions
                                                               6.   Wardlaw JM, Smith C, Dichgans M, 2013, Mechanisms
            Conceptualization: Serhan Karakiliç, Nevra Öksüz, Aynur   of sporadic cerebral small vessel disease: Insights from
               Özge                                               neuroimaging. Lancet Neurol, 12: 483–497.
            Formal analysis: Asena Ayça Özdemir                   https://doi.org/10.1016/S1474-4422(13)70060-7
            Investigation: Serhan Karakiliç, Nevra Öksüz, Reza Ghouri   7.   Greicius MD, Srivastava G, Reiss AL, et al., 2004, Default-
                                                                  mode network activity distinguishes Alzheimer’s disease
            Methodology: Aynur Özge                               from healthy aging: Evidence from functional MRI.  Proc

            Writing – original draft:  Serhan Karakiliç, Nevra Öksüz,   Natl Acad Sci U S A, 101: 4637–4642.
               Reza Ghouri, Aynur Özge                            https://doi.org/10.1073/pnas.0308627101
            Writing – review and editing: Nevra Öksüz, Aynur Özge  8.   Aarsland D, Creese B, Politis M,  et  al., 2017, Cognitive


            Volume 2 Issue 1 (2024)                         9                         https://doi.org/10.36922/bh.1712
   40   41   42   43   44   45   46   47   48   49   50